Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02878291Phase 1Unknown
Phase 1, open-label trial in meningococcal meningitis (2 arms), sponsored by Zhifei Green Bamboo. Primary endpoint: Occurrence of adverse events at 30 days. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02878291.